Compare EBS & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBS | FEIM |
|---|---|---|
| Founded | 1998 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 423.6M | 439.6M |
| IPO Year | 2006 | 1994 |
| Metric | EBS | FEIM |
|---|---|---|
| Price | $8.24 | $66.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $12.00 | ★ $51.50 |
| AVG Volume (30 Days) | ★ 728.7K | 140.5K |
| Earning Date | 04-30-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 125.83 | ★ 316.95 |
| EPS | 0.07 | ★ 0.41 |
| Revenue | ★ $742,900,000.00 | $69,811,000.00 |
| Revenue This Year | $1.29 | N/A |
| Revenue Next Year | N/A | $21.73 |
| P/E Ratio | ★ $113.57 | $163.27 |
| Revenue Growth | N/A | ★ 26.30 |
| 52 Week Low | $5.62 | $18.63 |
| 52 Week High | $14.06 | $76.07 |
| Indicator | EBS | FEIM |
|---|---|---|
| Relative Strength Index (RSI) | 46.88 | 52.02 |
| Support Level | $7.76 | $43.53 |
| Resistance Level | $8.54 | $76.07 |
| Average True Range (ATR) | 0.46 | 5.88 |
| MACD | -0.06 | -0.74 |
| Stochastic Oscillator | 34.78 | 49.08 |
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.